Skip to content

H.R. 6897 · 118th Congress (2023–2025)

Synthetic Biology and Active Pharmaceutical Ingredients Act

This bill requires the Department of Defense (DOD) to establish a pilot program to support domestic manufacturing of critical pharmaceutical ingredients and their components through certain novel technology.

Specifically, DOD must establish a three-year program that uses technology involving synthetic biology to support domestic manufacturing of pharmaceutical ingredients and related incorporated materials that (1) are not available in a sufficient quantity or quality domestically, and (2) are strategically important to the United States.

Show official title

To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is H.R. 6897’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Elissa Slotkin (D-MI-7)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Mike Gallagher (R-WI-8)· Original · Dec 22, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Armed Services.

    Sources
  3. Expired

    Introduced → Referred to House Armed Services → No further action before the 118th Congress ended.

Committees

  1. HouseArmed ServicesReferred Dec 22, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Synthetic Biology and Active Pharmaceutical Ingredients Act

    Display title, Short title · Introduced in House

  2. To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.

    Official title · Introduced in House